PUBLISHER: The Business Research Company | PRODUCT CODE: 1751067
PUBLISHER: The Business Research Company | PRODUCT CODE: 1751067
Oxygen conserving devices (OCDs) are medical devices designed to optimize oxygen delivery for patients with respiratory conditions. These devices minimize oxygen wastage by delivering it only during inhalation, rather than continuously, thus extending the life of oxygen tanks or concentrators.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of oxygen conserving devices include reservoir cannulas, transtracheal catheters, intermittent flow devices, continuous flow devices, and other products. A reservoir cannula is a type of nasal cannula that stores additional oxygen in a small chamber during exhalation. Oxygen-conserving devices are used to treat various conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and other respiratory disorders. They are utilized by different end-users, including hospitals and clinics, long-term care units, home care settings, and others.
The oxygen conserving devices market research report is one of a series of new reports from The Business Research Company that provides oxygen conserving devices market statistics, including oxygen conserving devices industry global market size, regional shares, competitors with an oxygen conserving devices market share, detailed oxygen conserving devices market segments, market trends and opportunities, and any further data you may need to thrive in the oxygen conserving devices industry. This oxygen conserving devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The oxygen conserving devices market size has grown rapidly in recent years. It will grow from$1.66 billion in 2024 to $1.92 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. The growth during the historic period can be attributed to factors such as the rising prevalence of respiratory diseases, an increasing elderly population, greater adoption of home healthcare, government initiatives supporting respiratory care, and a growing awareness about the importance of oxygen conservation.
The oxygen conserving devices market size is expected to see rapid growth in the next few years. It will grow to$3.41 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth during the forecast period can be attributed to factors such as the increasing demand for home-based oxygen therapy, a rising prevalence of chronic respiratory diseases, greater adoption of smart and connected healthcare devices, and expanding healthcare infrastructure. Key trends during this period include the use of artificial intelligence (AI) for oxygen flow regulation, the development of smart sensors for real-time oxygen monitoring, integration with the Internet of Medical Things (IoMT), cloud-based data tracking for patient management, and the advancement of adaptive and self-learning oxygen regulators.
The growing prevalence of chronic respiratory diseases is expected to drive the growth of the oxygen conserving devices market in the coming years. Chronic respiratory diseases are long-term conditions that affect the lungs and airways, making breathing difficult. These diseases are largely driven by continued smoking and tobacco use, which are major contributors to conditions such as COPD and lung cancer. Oxygen conserving devices are essential for individuals with chronic respiratory diseases as they provide efficient supplemental oxygen, improving comfort and mobility while ensuring sufficient oxygen levels. For example, in November 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that 2.8 million people (11%) were living with asthma in 2022. This contributed to 2.5% of the total disease burden and 35% of the respiratory disease burden in 2023, with 467 deaths (1.8 per 100,000 population) recorded in 2022, accounting for 0.2% of all deaths. As a result, the increasing incidence of chronic respiratory diseases is propelling the growth of the oxygen conserving devices market.
The expansion of healthcare infrastructure is also expected to accelerate the growth of the oxygen conserving devices market. Healthcare infrastructure includes the physical and organizational structures, facilities, systems, and resources required to effectively deliver healthcare services. As the prevalence of chronic diseases such as diabetes and heart conditions increases, there is a growing demand for specialized care facilities and resources to support long-term patient management. The development of healthcare infrastructure supports oxygen conserving devices by ensuring reliable access, efficient delivery, and proper maintenance in both medical facilities and homecare environments. For instance, in May 2023, the American Health Care Association, a nonprofit organization based in the US, reported that the United States had 6,129 hospitals, marking a 0.591% increase from the previous year when there were 6,093 hospitals. This growth in healthcare infrastructure is, therefore, driving the expansion of the oxygen conserving devices market.
In December 2022, Atlas Copco, a Sweden-based manufacturer of industrial tools and equipment, acquired Shandong Meditech Medical Technology Co. Ltd. for an undisclosed amount. Through this acquisition, Atlas aims to broaden its medical gas solutions portfolio, strengthen its presence in the healthcare sector, and enhance onsite oxygen generation capabilities. Meditech, a China-based medical device company, specializes in developing and manufacturing oxygen conservers and other respiratory care products, and this acquisition will enable Atlas to leverage Meditech's expertise while expanding its service reach globally.
Major players in the oxygen conserving devices market are Medline Industries LP, Ballad Health, Drive DeVilbiss Healthcare LLC, React Health, GF Health Products Inc., Essex Industries Inc., Compass Health Brands, Sunset Healthcare Solutions Inc., Vitality Medical Inc., First Nation Group LLC, CHAD Therapeutics, Precision Medical Inc., Cobalt Health, Tri-Med Inc., Air Liquide Healthcare, Inovo Inc., HERSILL, Beechfield Healthcare, GCE Group, and Responsive Respiratory Inc.
North America was the largest region in the oxygen conserving devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in oxygen conserving devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the oxygen conserving devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The oxygen conserving devices market consists of sales of pulse-dose oxygen conservers, continuous-flow oxygen conservers, electronic oxygen conservers, pneumatic oxygen conservers, and reservoir cannulas. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Oxygen Conserving Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on oxygen conserving devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for oxygen conserving devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oxygen conserving devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.